Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7953
-0.0447 (-5.32%)
At close: May 8, 2026, 4:00 PM EDT
0.8000
+0.0047 (0.59%)
After-hours: May 8, 2026, 7:27 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $19.83 million as of May 8, 2026. Its market cap has increased by 326.27% in one year.
Market Cap
19.83M
Enterprise Value
-35.32M
1-Year Change
326.27%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $19.83M, a decrease of -69.62%. That is a compound annual growth rate of -22.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 19.83M | -33.41% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 23.99M |
| AEON Biopharma | 22.91M |
| Allarity Therapeutics | 22.88M |
| VYNE Therapeutics | 22.31M |
| Exicure | 21.61M |
| Quince Therapeutics | 19.89M |
| Lipocine | 19.50M |
| SeaStar Medical Holding | 19.45M |